We recently compiled a list of the 13 Best Dividend Stocks to Buy Under $50. In this article, we are going to take a look at ...

We recently published a list of the 8 Best Dividend Leaders to Buy According to Wall Street Analysts. In this article, we are ...

Pfizer trades at a 21.7% discount to peers on a 1-yr forward P/E basis, which is a point for the bullish arguments. Find out ...

Pfizer's oncology promises are several years from being actualized. Read why investors shouldn't assume that a sustained ...

Despite today’s strength, Pfizer shares are trading deep in a long-term bear market trend. The stock crossed into bearish ...

As of the latest trading close, PFE, a Healthcare sector stock, is trading -18.90% below its 52-week high but remains 4.49% above its 52-week low. The Average True Range (ATR) (14 days) of 0.55 ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Pfizer (NYSE: PFE) shares rose nearly 3% to $25.98 in premarket trading on December 17 after the pharmaceutical giant ...

Pfizer Inc. (NYSE:PFE) will conduct an investor call on Tuesday to provide full-year 2025 financial guidance. Ahead of the ...

Pfizer Inc.'s ( NYSE:PFE) periodic dividend will be increasing on the 7th of March to $0.43, with investors receiving 2.4% ...

Pfizer (PFE) issued its full-year 2025 guidance and reaffirmed full-year 2024 guidance. Pfizer expects 2025 adjusted EPS to be in a ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other best dividend leaders to buy. Investors have long been drawn to dividend stocks due to their ...